Stay updated on NRP 104 Likeability & Safety in Stimulant Abuse Clinical Trial

Sign up to get notified when there's something new on the NRP 104 Likeability & Safety in Stimulant Abuse Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the NRP 104 Likeability & Safety in Stimulant Abuse Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page footer’s version/revision indicator was updated from v3.5.2 to v3.5.3.
    Difference
    0.1%
    Check dated 2026-04-24T06:18:26.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision indicator updated to v3.5.2, replacing the previous v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T02:45:18.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    39 days ago
    Change Detected
    Summary
    Revision metadata updated to v3.5.0. The prior v3.4.3 revision was removed.
    Difference
    0.1%
    Check dated 2026-03-19T06:08:32.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T02:18:42.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The page layout has been refreshed and sections reorganized, but the actual study details, eligibility criteria, and contact information remain unchanged.
    Difference
    0.1%
    Check dated 2026-03-05T00:21:51.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    A new site revision (v3.4.2) is visible and the prior government-funding status notice was removed, both indicating a minor UI/operational update without affecting the study details.
    Difference
    0.5%
    Check dated 2026-02-11T14:09:08.000Z thumbnail image

Stay in the know with updates to NRP 104 Likeability & Safety in Stimulant Abuse Clinical Trial

Enter your email address, and we'll notify you when there's something new on the NRP 104 Likeability & Safety in Stimulant Abuse Clinical Trial page.